NRX Pharmaceuticals Inc [NRXP] stock is trading at $0.52, up 18.69%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NRXP shares have gain 21.61% over the last week, with a monthly amount glided 39.07%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, March 2024, NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression. In a post published today on Yahoo Finance, Marks a major step in the development of what could be the first drug approved for Suicidal Bipolar Depression.
From an analyst’s perspective:
NRX Pharmaceuticals Inc [NRXP] stock has fluctuated between $0.22 and $1.20 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. NRX Pharmaceuticals Inc [NASDAQ: NRXP] shares were valued at $0.52 at the most recent close of the market. An investor can expect a potential return of 284.62% based on the average NRXP price forecast.
Analyzing the NRXP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.53, Equity is 69.77 and Total Capital is 5.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4467 points at the first support level, and at 0.3734 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5716, and for the 2nd resistance point, it is at 0.6232.
NRX Pharmaceuticals Inc [NRXP] reported earnings per share of -$0.07 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.11/share, meaning a difference of $0.04 and a surprise factor of 36.40%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.12 per share as compared to estimates of -$0.14 per share, a difference of $0.02 representing a surprise of 14.30%.
Ratios To Look Out For
For context, NRX Pharmaceuticals Inc’s Current Ratio is 0.68. As well, the Quick Ratio is 0.68, while the Cash Ratio is 0.46.
Transactions by insiders
Recent insider trading involved Hurvitz Chaim, Director, that happened on Aug 30 when 70000.0 shares were purchased. Director, Gorovitz Aaron completed a deal on Aug 30 to buy 35000.0 shares. Meanwhile, Chief Scientist Javitt Jonathan C bought 100000.0 shares on Aug 23.
